| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.909 | 0.002 | 0.909 | Alcohol oxidase inhibitor | 0.425 0.004 DB01828 0.073 0.027 DB00166 | ||
| 0.853 | 0.001 | 0.853 | GABA C receptor agonist | 0.571 0.003 DB01828 0.12 0.05 DBMET03082 0.443 0.004 DB00166 | ||
| 0.792 | 0.002 | 0.792 | Porphobilinogen synthase inhibitor | 0.275 0.006 DB01828 0.112 0.031 DBMET03082 0.2 0.012 DB00166 | ||
| 0.752 | 0.004 | 0.752 | Superoxide dismutase inhibitor | 0.419 0.024 DB01828 0.397 0.027 DBMET03082 0.187 0.132 DB00166 | ||
| 0.717 | 0.003 | 0.717 | Alpha-N-acetylglucosaminidase inhibitor | 0.504 0.005 DB01828 0.104 0.096 DBMET03082 0.237 0.025 DB00166 | ||
| 0.685 | 0.002 | 0.726 | Glutamate decarboxylase inhibitor | 0.195 0.007 DB01828 0.726 0.002 DBMET03082 0.245 0.004 DB00166 | DBMET03082 | |
| 0.667 | 0.003 | 0.667 | Peroxidase inhibitor | 0.507 0.009 DB01828 0.474 0.012 DBMET03082 0.138 0.085 DB00166 | ||
| 0.669 | 0.011 | 0.669 | Aldehyde oxidase inhibitor | 0.628 0.015 DB01828 0.235 0.088 DBMET03082 0.145 0.144 DB00166 | ||
| 0.624 | 0.012 | 0.672 | 5 Hydroxytryptamine release stimulant | 0.672 0.009 DB01828 | DB01828 | |
| 0.629 | 0.023 | 0.915 | Cyclophilin D inhibitor | 0.915 0.004 DB00166 | DB00166 | |
| 0.598 | 0.002 | 0.598 | Glutamate dehydrogenase inhibitor | 0.242 0.008 DB01828 0.338 0.005 DBMET03082 0.19 0.011 DB00166 | ||
| 0.587 | 0.002 | 0.587 | Phenylalanine 4-hydroxylase inhibitor | 0.213 0.006 DB01828 0.148 0.012 DBMET03082 0.089 0.031 DB00166 | ||
| 0.585 | 0.007 | 0.629 | Platelet antagonist | 0.629 0.005 DB00166 | DB00166 | |
| 0.554 | 0.002 | 0.554 | Ornithine carbamoyltransferase inhibitor | 0.125 0.012 DB01828 0.244 0.005 DBMET03082 0.076 0.023 DB00166 | ||
| 0.555 | 0.003 | 0.555 | Tyrosine 3 hydroxylase inhibitor | 0.427 0.006 DB01828 0.263 0.056 DB00166 | ||
| 0.557 | 0.013 | 0.597 | GABA C receptor rho-3 antagonist | 0.597 0.008 DB01828 | DB01828 | |
| 0.548 | 0.02 | 0.548 | 5 Hydroxytryptamine release inhibitor | 0.485 0.038 DB01828 0.288 0.179 DB00166 | ||
| 0.532 | 0.004 | 0.654 | Chelator | 0.436 0.005 DBMET03082 0.654 0.003 DB00166 | DB00166 | |
| 0.534 | 0.013 | 0.81 | Hypoglycemic | 0.81 0.004 DB00166 | DB00166 | |
| 0.515 | 0.002 | 0.515 | Ferrochelatase inhibitor | 0.42 0.003 DB01828 0.117 0.056 DBMET03082 0.196 0.023 DB00166 | ||
| 0.506 | 0.003 | 0.506 | Histidine decarboxylase inhibitor | 0.227 0.01 DB01828 0.157 0.018 DBMET03082 0.068 0.052 DB00166 | ||
| 0.505 | 0.006 | 0.505 | Phospholipase C inhibitor | 0.243 0.026 DB01828 0.278 0.02 DBMET03082 0.275 0.021 DB00166 | ||
| 0.527 | 0.028 | 0.527 | Cholesterol antagonist | 0.33 0.074 DB01828 0.455 0.04 DB00166 | ||
| 0.518 | 0.023 | 0.518 | Histamine release inhibitor | 0.423 0.064 DB01828 0.318 0.114 DB00166 | ||
| 0.48 | 0.004 | 0.48 | Peptidyltransferase inhibitor | 0.317 0.019 DB01828 | ||
| 0.48 | 0.005 | 0.482 | 5 Hydroxytryptamine uptake stimulant | 0.482 0.005 DB01828 0.28 0.057 DB00166 | DB01828 | |
| 0.483 | 0.011 | 0.483 | Anticoagulant | |||
| 0.48 | 0.01 | 0.48 | Interleukin 2 agonist | 0.23 0.143 DB01828 0.387 0.031 DB00166 | ||
| 0.468 | 0.003 | 0.468 | GABA C receptor antagonist | 0.355 0.004 DB01828 0.099 0.08 DBMET03082 0.104 0.072 DB00166 | ||
| 0.466 | 0.006 | 0.466 | Sodium/bile acid cotransporter inhibitor | 0.397 0.018 DB00166 | ||
| 0.427 | 0.002 | 0.427 | NMDA receptor agonist | 0.123 0.013 DB01828 0.078 0.03 DBMET03082 0.102 0.019 DB00166 | ||
| 0.426 | 0.004 | 0.426 | Succinate dehydrogenase inhibitor | 0.294 0.012 DB01828 0.324 0.008 DBMET03082 0.288 0.013 DB00166 | ||
| 0.429 | 0.012 | 0.685 | Growth hormone agonist | 0.137 0.099 DB01828 0.298 0.033 DBMET03082 0.685 0.003 DB00166 | DB00166 | |
| 0.419 | 0.004 | 0.419 | NADH dehydrogenase inhibitor | 0.211 0.01 DB01828 | ||
| 0.449 | 0.038 | 0.61 | Antithrombotic | 0.249 0.127 DB01828 0.61 0.015 DB00166 | DB00166 | |
| 0.411 | 0.003 | 0.411 | Adenylate kinase inhibitor | 0.297 0.007 DB01828 0.172 0.02 DBMET03082 0.22 0.013 DB00166 | ||
| 0.415 | 0.01 | 0.415 | Thrombolytic | 0.309 0.022 DBMET03082 0.234 0.038 DB00166 | ||
| 0.406 | 0.003 | 0.406 | Triose-phosphate isomerase inhibitor | 0.246 0.007 DB01828 0.23 0.008 DB00166 | ||
| 0.407 | 0.006 | 0.407 | DNA polymerase I inhibitor | 0.237 0.019 DB00166 | ||
| 0.413 | 0.017 | 0.413 | Interleukin agonist | 0.319 0.039 DB01828 0.224 0.099 DB00166 | ||
| 0.464 | 0.076 | 0.464 | Caspase 9 stimulant | 0.442 0.087 DB01828 | ||
| 0.39 | 0.003 | 0.39 | Carbamoyl phosphate synthetase inhibitor | 0.226 0.006 DB01828 0.071 0.034 DBMET03082 0.157 0.01 DB00166 | ||
| 0.407 | 0.021 | 0.407 | Insulysin inhibitor | 0.332 0.041 DB01828 0.365 0.029 DBMET03082 0.352 0.033 DB00166 | ||
| 0.446 | 0.064 | 0.557 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.557 0.014 DB01828 | DB01828 | |
| 0.397 | 0.022 | 0.916 | Angiogenesis stimulant | 0.916 0.001 DBMET03082 0.331 0.038 DB00166 | DBMET03082 | |
| 0.474 | 0.099 | 0.848 | Antiinflammatory | 0.848 0.009 DB00166 | DB00166 | |
| 0.436 | 0.062 | 0.436 | Antibacterial | 0.219 0.208 DB01828 0.244 0.182 DB00166 | ||
| 0.394 | 0.022 | 0.394 | DNA synthesis inhibitor | 0.33 0.035 DB01828 0.186 0.144 DBMET03082 0.237 0.076 DB00166 | ||
| 0.41 | 0.041 | 0.694 | Immunomodulator | 0.694 0.005 DB00166 | DB00166 | |
| 0.382 | 0.019 | 0.382 | Anesthetic general | 0.334 0.026 DB01828 0.195 0.077 DB00166 | ||
| 0.386 | 0.03 | 0.386 | Calcium channel activator | 0.382 0.032 DB01828 | ||
| 0.354 | 0.004 | 0.354 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.246 0.01 DB01828 0.098 0.056 DBMET03082 0.268 0.008 DB00166 | ||
| 0.351 | 0.003 | 0.351 | GABA C receptor rho-1 antagonist | 0.282 0.004 DB01828 | ||
| 0.35 | 0.008 | 0.35 | Aldehyde dehydrogenase inhibitor | 0.187 0.031 DB01828 | ||
| 0.384 | 0.054 | 0.42 | Immunostimulant | 0.226 0.106 DB01828 0.42 0.044 DBMET03082 0.376 0.057 DB00166 | DBMET03082 | |
| 0.365 | 0.037 | 0.365 | DNA damaging | 0.226 0.096 DB01828 0.183 0.131 DB00166 | ||
| 0.334 | 0.007 | 0.391 | Aminopeptidase B inhibitor | 0.199 0.022 DB01828 0.391 0.005 DBMET03082 0.192 0.023 DB00166 | DBMET03082 | |
| 0.397 | 0.083 | 0.414 | Calcium channel L-type activator | 0.414 0.072 DB01828 | DB01828 | |
| 0.34 | 0.031 | 0.34 | Anticonvulsant | 0.239 0.061 DB00166 | ||
| 0.311 | 0.003 | 0.311 | Biliverdin reductase inhibitor | 0.205 0.005 DB01828 0.1 0.018 DB00166 | ||
| 0.359 | 0.052 | 0.883 | Apoptosis antagonist | 0.883 0.003 DB00166 | DB00166 | |
| 0.324 | 0.019 | 0.326 | Gastrin inhibitor | 0.289 0.041 DB01828 0.326 0.018 DB00166 | DB00166 | |
| 0.319 | 0.018 | 0.319 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.289 0.027 DB01828 | ||
| 0.302 | 0.002 | 0.302 | Glycine receptor agonist | 0.125 0.011 DB01828 0.082 0.036 DB00166 | ||
| 0.303 | 0.005 | 0.408 | Alcohol dehydrogenase inhibitor | 0.128 0.029 DB01828 0.408 0.004 DBMET03082 0.11 0.043 DB00166 | DBMET03082 | |
| 0.301 | 0.006 | 0.301 | Catalase inhibitor | 0.169 0.022 DB01828 0.233 0.01 DBMET03082 0.184 0.018 DB00166 | ||
| 0.298 | 0.004 | 0.298 | Argininosuccinate synthase inhibitor | 0.185 0.009 DB01828 0.1 0.019 DB00166 | ||
| 0.298 | 0.005 | 0.298 | Phosphofructokinase-1 inhibitor | 0.218 0.009 DB01828 0.105 0.03 DBMET03082 0.21 0.01 DB00166 | ||
| 0.35 | 0.059 | 0.35 | Caspase 3 stimulant | |||
| 0.292 | 0.005 | 0.292 | Erythropoietin receptor agonist | 0.079 0.013 DB00166 | ||
| 0.29 | 0.004 | 0.29 | GABA aminotransferase inhibitor | 0.141 0.009 DB01828 0.083 0.043 DB00166 | ||
| 0.32 | 0.038 | 0.32 | Psychostimulant | 0.282 0.048 DB01828 0.182 0.091 DB00166 | ||
| 0.334 | 0.058 | 0.334 | Spasmolytic | 0.191 0.128 DB01828 | ||
| 0.295 | 0.019 | 0.295 | Amylase inhibitor | 0.132 0.074 DB01828 | ||
| 0.287 | 0.015 | 0.29 | Nitric-oxide synthase stimulant | 0.29 0.014 DB01828 | DB01828 | |
| 0.334 | 0.064 | 0.334 | Vasodilator, coronary | 0.31 0.08 DB01828 0.219 0.164 DB00166 | ||
| 0.274 | 0.005 | 0.274 | Creatine kinase inhibitor | 0.225 0.007 DB01828 0.09 0.071 DB00166 | ||
| 0.269 | 0.002 | 0.269 | Aconitate hydratase inhibitor | 0.139 0.005 DB01828 0.125 0.005 DB00166 | ||
| 0.269 | 0.004 | 0.269 | HIV-1 integrase (Overall Integration) inhibitor | 0.178 0.017 DB01828 | ||
| 0.268 | 0.004 | 0.268 | Aminopeptidase I inhibitor | 0.145 0.013 DB01828 0.231 0.005 DBMET03082 0.13 0.017 DB00166 | ||
| 0.267 | 0.003 | 0.267 | Fumarate hydratase inhibitor | 0.086 0.006 DB01828 0.056 0.011 DB00166 | ||
| 0.269 | 0.005 | 0.269 | Mucolytic | 0.16 0.027 DB01828 0.214 0.011 DBMET03082 0.177 0.02 DB00166 | ||
| 0.276 | 0.014 | 0.37 | Alkylator | 0.153 0.045 DB01828 0.37 0.009 DB00166 | DB00166 | |
| 0.276 | 0.016 | 0.276 | Adenylate cyclase inhibitor | 0.15 0.045 DB01828 | ||
| 0.28 | 0.021 | 0.673 | Insulin sensitizer | 0.197 0.076 DB01828 0.673 0.003 DB00166 | DB00166 | |
| 0.268 | 0.011 | 0.268 | Expectorant | 0.134 0.042 DB01828 0.206 0.019 DBMET03082 0.164 0.03 DB00166 | ||
| 0.263 | 0.008 | 0.263 | Carbonic anhydrase III inhibitor | 0.172 0.022 DB01828 0.098 0.064 DBMET03082 0.093 0.071 DB00166 | ||
| 0.302 | 0.047 | 0.664 | Interleukin antagonist | 0.664 0.006 DBMET03082 | DBMET03082 | |
| 0.261 | 0.008 | 0.261 | NMDA receptor antagonist | |||
| 0.26 | 0.014 | 0.26 | Cystathionine beta-synthase inhibitor | 0.215 0.021 DB01828 0.097 0.08 DB00166 | ||
| 0.25 | 0.004 | 0.25 | Adenylate cyclase stimulant | 0.208 0.01 DB01828 0.153 0.058 DB00166 | ||
| 0.263 | 0.019 | 0.263 | Neurotensin receptor agonist | 0.196 0.037 DB01828 0.147 0.109 DBMET03082 0.139 0.132 DB00166 | ||
| 0.256 | 0.015 | 0.256 | Cell wall synthesis inhibitor | 0.196 0.032 DB01828 0.114 0.109 DBMET03082 | ||
| 0.276 | 0.037 | 0.321 | RNA-directed DNA polymerase inhibitor | 0.321 0.028 DB01828 | DB01828 | |
| 0.239 | 0.003 | 0.239 | GABA B receptor agonist | 0.122 0.007 DB01828 0.117 0.008 DB00166 | ||
| 0.239 | 0.003 | 0.239 | Acyl-CoA dehydrogenase inhibitor | 0.217 0.004 DB01828 0.095 0.017 DBMET03082 0.072 0.026 DB00166 | ||
| 0.243 | 0.009 | 0.243 | Carbonic anhydrase VI inhibitor | 0.115 0.031 DB01828 | ||
| 0.296 | 0.063 | 0.959 | Antioxidant | 0.553 0.015 DBMET03082 0.959 0.003 DB00166 | DB00166 | |
| 0.236 | 0.003 | 0.236 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.316 | 0.089 | 0.316 | Vasodilator, peripheral | 0.296 0.099 DB01828 0.241 0.134 DB00166 | ||
| 0.266 | 0.04 | 0.266 | DNA methylase inhibitor | 0.17 0.101 DB01828 | ||
| 0.325 | 0.1 | 0.325 | Antiobesity | 0.294 0.12 DB00166 | ||
| 0.23 | 0.007 | 0.23 | Antineoplastic alkaloid | |||
| 0.237 | 0.015 | 0.278 | GABA C receptor rho-2 antagonist | 0.278 0.007 DB01828 | DB01828 | |
| 0.226 | 0.006 | 0.226 | Aldose reductase inhibitor | |||
| 0.24 | 0.021 | 0.316 | 5 Hydroxytryptamine 3E antagonist | 0.316 0.004 DB01828 | DB01828 | |
| 0.231 | 0.015 | 0.231 | UDP-glucose 4-epimerase inhibitor | 0.229 0.015 DB01828 | ||
| 0.22 | 0.009 | 0.22 | Photosensitizer | 0.17 0.021 DB01828 0.137 0.04 DB00166 | ||
| 0.237 | 0.027 | 0.344 | Phospholipase A2 inhibitor | 0.126 0.107 DB01828 0.152 0.072 DBMET03082 0.344 0.008 DB00166 | DB00166 | |
| 0.23 | 0.02 | 0.23 | Topoisomerase I inhibitor | |||
| 0.249 | 0.039 | 0.249 | Neurotrophic factor enhancer | 0.243 0.043 DB01828 0.175 0.104 DB00166 | ||
| 0.224 | 0.015 | 0.224 | Toll-Like receptor 2 antagonist | 0.149 0.053 DB01828 0.106 0.095 DB00166 | ||
| 0.215 | 0.006 | 0.215 | Electrolyte absorption antagonist | 0.172 0.013 DB01828 0.092 0.07 DB00166 | ||
| 0.22 | 0.013 | 0.22 | Cyclooxygenase 3 inhibitor | 0.147 0.051 DB01828 0.108 0.092 DB00166 | ||
| 0.212 | 0.005 | 0.212 | DOPA decarboxylase inhibitor | 0.176 0.011 DB01828 0.095 0.085 DB00166 | ||
| 0.209 | 0.003 | 0.209 | NMDA receptor glycine site agonist | 0.107 0.013 DB01828 | ||
| 0.221 | 0.015 | 0.221 | Carbonic anhydrase XV inhibitor | 0.206 0.018 DB01828 | ||
| 0.279 | 0.077 | 0.279 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.21 | 0.009 | 0.21 | Hematopoietic | 0.081 0.07 DB00166 | ||
| 0.205 | 0.005 | 0.205 | Ornithine decarboxylase inhibitor | 0.115 0.03 DB01828 0.119 0.027 DB00166 | ||
| 0.226 | 0.025 | 0.226 | Hemostatic | 0.132 0.093 DB01828 0.156 0.061 DB00166 | ||
| 0.219 | 0.02 | 0.219 | Cell adhesion inhibitor | 0.117 0.067 DB00166 | ||
| 0.231 | 0.034 | 0.276 | Diuretic | 0.121 0.103 DB01828 0.166 0.064 DBMET03082 0.276 0.027 DB00166 | DB00166 | |
| 0.203 | 0.006 | 0.203 | GP IIb/IIIa receptor antagonist | 0.155 0.01 DB00166 | ||
| 0.228 | 0.033 | 0.58 | Protein kinase stimulant | 0.169 0.056 DB01828 0.58 0.003 DB00166 | DB00166 | |
| 0.216 | 0.023 | 0.216 | Mannose-6-phosphate isomerase inhibitor | 0.208 0.026 DB01828 | ||
| 0.239 | 0.046 | 0.727 | Hepatoprotectant | 0.328 0.023 DBMET03082 0.727 0.004 DB00166 | DB00166 | |
| 0.214 | 0.021 | 0.214 | Arachidonic acid antagonist | 0.206 0.028 DB01828 0.193 0.04 DB00166 | ||
| 0.217 | 0.025 | 0.217 | Histone deacetylase SIRT1 inhibitor | 0.117 0.095 DB01828 0.116 0.096 DBMET03082 | ||
| 0.19 | 0.003 | 0.19 | Mannosidase inhibitor | 0.084 0.008 DB01828 0.066 0.014 DBMET03082 0.059 0.017 DB00166 | ||
| 0.215 | 0.029 | 0.633 | Insulin secretagoues | 0.633 0.004 DB00166 | DB00166 | |
| 0.227 | 0.042 | 0.227 | Lipocortins synthesis antagonist | 0.164 0.087 DB01828 0.177 0.073 DB00166 | ||
| 0.192 | 0.007 | 0.192 | Potassium channel large-conductance Ca-activated activator | |||
| 0.235 | 0.053 | 0.235 | DNA methyltransferase I inhibitor | 0.156 0.098 DB01828 0.133 0.125 DB00166 | ||
| 0.192 | 0.012 | 0.192 | Aminoacyl-tRNA synthetase inhibitor | 0.096 0.05 DBMET03082 | ||
| 0.204 | 0.024 | 0.213 | DNA intercalator | 0.213 0.022 DBMET03082 0.096 0.078 DB00166 | DBMET03082 | |
| 0.194 | 0.015 | 0.194 | Carbonic anhydrase XIII inhibitor | 0.098 0.039 DB01828 | ||
| 0.188 | 0.01 | 0.244 | Thioredoxin inhibitor | 0.244 0.005 DB00166 | DB00166 | |
| 0.178 | 0.002 | 0.178 | Lysine carboxypeptidase inhibitor | 0.039 0.011 DB01828 0.082 0.004 DBMET03082 0.041 0.01 DB00166 | ||
| 0.193 | 0.018 | 0.193 | MAP3K9 inhibitor | |||
| 0.179 | 0.007 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.18 0.007 DB01828 0.156 0.03 DB00166 | DB01828 | |
| 0.175 | 0.003 | 0.175 | Glutamate (mGluR6) antagonist | 0.121 0.005 DB01828 0.126 0.005 DB00166 | ||
| 0.176 | 0.005 | 0.176 | Sphingosine 1-phosphate receptor 4 agonist | 0.122 0.016 DB01828 | ||
| 0.186 | 0.016 | 0.186 | Vanilloid 1 agonist | 0.142 0.047 DB01828 0.148 0.04 DB00166 | ||
| 0.187 | 0.018 | 0.187 | Sphingosine 1-phosphate receptor 5 antagonist | 0.176 0.027 DB01828 | ||
| 0.203 | 0.034 | 0.203 | ATPase inhibitor | 0.185 0.052 DB01828 | ||
| 0.172 | 0.004 | 0.172 | Alpha-mannosidase inhibitor | 0.094 0.007 DB01828 0.071 0.016 DBMET03082 0.062 0.025 DB00166 | ||
| 0.18 | 0.013 | 0.195 | Prolactin inhibitor | 0.195 0.01 DB01828 0.108 0.048 DB00166 | DB01828 | |
| 0.178 | 0.01 | 0.178 | Keratolytic | 0.096 0.033 DB01828 | ||
| 0.178 | 0.013 | 0.178 | Heat shock protein 70 antagonist | 0.167 0.02 DB01828 | ||
| 0.221 | 0.057 | 0.221 | Non-steroidal antiinflammatory agent | 0.138 0.134 DB01828 | ||
| 0.2 | 0.036 | 0.2 | Bone formation stimulant | 0.193 0.037 DB00166 | ||
| 0.238 | 0.076 | 0.557 | Antiamyloidogenic | 0.169 0.124 DBMET03082 0.557 0.011 DB00166 | DB00166 | |
| 0.167 | 0.008 | 0.167 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.129 0.01 DB01828 | ||
| 0.166 | 0.007 | 0.183 | Glutamate release inhibitor | 0.183 0.005 DB01828 0.095 0.051 DB00166 | DB01828 | |
| 0.184 | 0.028 | 0.186 | Cathepsin H inhibitor | 0.186 0.027 DB01828 | DB01828 | |
| 0.164 | 0.008 | 0.164 | Lanosterol 14 alpha demethylase inhibitor | 0.128 0.023 DB01828 0.087 0.077 DB00166 | ||
| 0.165 | 0.01 | 0.165 | Carbonic anhydrase stimulant | 0.093 0.021 DB01828 | ||
| 0.166 | 0.012 | 0.166 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.268 | 0.115 | 0.549 | Transcription factor NF kappa B inhibitor | 0.211 0.159 DB01828 0.549 0.038 DB00166 | DB00166 | |
| 0.157 | 0.006 | 0.157 | NMDA 2C receptor antagonist | 0.078 0.026 DB01828 | ||
| 0.172 | 0.021 | 0.172 | Potassium channel (Ca-activated) activator | 0.092 0.062 DB01828 | ||
| 0.212 | 0.065 | 0.741 | Platelet adhesion inhibitor | 0.741 0.003 DB00166 | DB00166 | |
| 0.192 | 0.046 | 0.192 | Interleukin 6 antagonist | |||
| 0.168 | 0.022 | 0.168 | Sphingosine 1-phosphate receptor 2 antagonist | 0.162 0.028 DB01828 0.115 0.109 DB00166 | ||
| 0.159 | 0.016 | 0.159 | Glutamate receptor agonist | |||
| 0.17 | 0.027 | 0.243 | Nav1.4 sodium channel blocker | 0.095 0.083 DB01828 0.243 0.01 DB00166 | DB00166 | |
| 0.16 | 0.019 | 0.165 | Folate antagonist | 0.09 0.086 DB01828 0.165 0.018 DB00166 | DB00166 | |
| 0.224 | 0.083 | 0.225 | Neuropeptide Y2 antagonist | 0.225 0.083 DB01828 0.184 0.15 DBMET03082 | DB01828 | |
| 0.145 | 0.005 | 0.145 | Kainate receptor antagonist | 0.044 0.025 DB01828 | ||
| 0.151 | 0.012 | 0.156 | Glutathione S-transferase inhibitor | 0.101 0.037 DB01828 0.156 0.011 DBMET03082 | DBMET03082 | |
| 0.167 | 0.027 | 0.222 | 5 Hydroxytryptamine 3A agonist | 0.222 0.01 DB01828 | DB01828 | |
| 0.151 | 0.014 | 0.171 | Histamine N-methyltransferase inhibitor | 0.171 0.009 DB01828 | DB01828 | |
| 0.153 | 0.016 | 0.153 | Anabolic | 0.139 0.024 DB01828 0.106 0.055 DBMET03082 0.117 0.042 DB00166 | ||
| 0.139 | 0.004 | 0.139 | Glutamate (mGluR3) antagonist | 0.063 0.008 DB01828 0.04 0.02 DB00166 | ||
| 0.143 | 0.008 | 0.143 | Neuraminidase (influenza) inhibitor | |||
| 0.161 | 0.027 | 0.161 | Interleukin 8 antagonist | 0.134 0.046 DB01828 | ||
| 0.144 | 0.011 | 0.237 | Integrin antagonist | 0.237 0.005 DB00166 | DB00166 | |
| 0.148 | 0.015 | 0.148 | Carbonic anhydrase V inhibitor | 0.086 0.033 DB01828 | ||
| 0.143 | 0.009 | 0.143 | Carbonic anhydrase VB inhibitor | 0.095 0.017 DB01828 | ||
| 0.267 | 0.134 | 0.267 | Toll-Like receptor agonist | |||
| 0.134 | 0.003 | 0.134 | Arginase inhibitor | 0.066 0.009 DB01828 0.054 0.013 DBMET03082 0.053 0.014 DB00166 | ||
| 0.168 | 0.039 | 0.168 | Glutamate receptor antagonist | |||
| 0.137 | 0.012 | 0.146 | Toll-Like receptor 2 agonist | 0.061 0.02 DB01828 0.146 0.011 DBMET03082 0.038 0.031 DB00166 | DBMET03082 | |
| 0.133 | 0.008 | 0.133 | NMDA 2A receptor antagonist | 0.063 0.028 DB01828 | ||
| 0.132 | 0.008 | 0.132 | NMDA receptor subunit 3B antagonist | 0.047 0.028 DB01828 | ||
| 0.177 | 0.052 | 0.177 | Interferon gamma antagonist | 0.164 0.062 DB01828 0.141 0.091 DB00166 | ||
| 0.136 | 0.011 | 0.136 | Glycine receptor antagonist | 0.118 0.019 DB01828 | ||
| 0.137 | 0.013 | 0.137 | Antimetabolite | 0.049 0.032 DB01828 0.091 0.018 DB00166 | ||
| 0.147 | 0.024 | 0.425 | Nitric-oxide synthase inhibitor | 0.147 0.024 DB01828 0.425 0.003 DB00166 | DB00166 | |
| 0.126 | 0.004 | 0.126 | Glutamate (mGluR4) antagonist | 0.067 0.011 DB01828 | ||
| 0.164 | 0.043 | 0.164 | Anesthetic local | 0.129 0.06 DB01828 | ||
| 0.13 | 0.01 | 0.13 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.01 DB01828 | ||
| 0.134 | 0.014 | 0.134 | Carbonic anhydrase VA inhibitor | 0.088 0.031 DB01828 | ||
| 0.141 | 0.021 | 0.141 | Interleukin 1 beta converting enzyme inhibitor | 0.085 0.08 DB01828 | ||
| 0.137 | 0.018 | 0.145 | Glutamate (mGluR7) agonist | 0.145 0.014 DB01828 | DB01828 | |
| 0.158 | 0.041 | 0.158 | Cholesterol synthesis inhibitor | 0.108 0.077 DB01828 0.146 0.047 DB00166 | ||
| 0.136 | 0.019 | 0.136 | Cell adhesion molecule inhibitor | |||
| 0.136 | 0.019 | 0.315 | Inducible nitric-oxide synthase inhibitor | 0.123 0.024 DB01828 0.315 0.004 DB00166 | DB00166 | |
| 0.149 | 0.034 | 0.153 | Sphingosine 1-phosphate receptor 4 antagonist | 0.153 0.031 DB01828 | DB01828 | |
| 0.224 | 0.108 | 0.224 | Transcription factor STAT inhibitor | 0.219 0.113 DB01828 | ||
| 0.172 | 0.057 | 0.172 | Melanin inhibitor | 0.151 0.08 DB01828 0.128 0.118 DB00166 | ||
| 0.223 | 0.108 | 0.223 | Transcription factor STAT3 inhibitor | 0.215 0.116 DB01828 | ||
| 0.166 | 0.052 | 0.216 | CF transmembrane conductance regulator agonist | 0.216 0.014 DB01828 | DB01828 | |
| 0.126 | 0.011 | 0.126 | Neurotensin receptor antagonist | |||
| 0.119 | 0.004 | 0.119 | AMPA 4 receptor antagonist | 0.049 0.016 DB01828 | ||
| 0.117 | 0.004 | 0.117 | Glucose-6-phosphate isomerase inhibitor | 0.088 0.007 DB01828 0.103 0.005 DB00166 | ||
| 0.119 | 0.007 | 0.119 | Phospholipase D inhibitor | 0.096 0.017 DB01828 0.066 0.064 DBMET03082 | ||
| 0.126 | 0.016 | 0.126 | ATPase (Vacuolar H+) inhibitor | |||
| 0.119 | 0.01 | 0.119 | Neuraminidase inhibitor | |||
| 0.122 | 0.013 | 0.122 | D-Ala-D-Ala ligase inhibitor | 0.12 0.013 DB01828 | ||
| 0.111 | 0.003 | 0.111 | Glutamate (mGluR8) agonist | 0.078 0.004 DB01828 0.069 0.005 DB00166 | ||
| 0.113 | 0.005 | 0.113 | Glutamate (mGluR group III) antagonist | 0.07 0.009 DB01828 | ||
| 0.215 | 0.106 | 0.469 | Cardiotonic | 0.243 0.087 DBMET03082 0.469 0.019 DB00166 | DB00166 | |
| 0.111 | 0.003 | 0.111 | Kainate receptor agonist | 0.081 0.004 DB01828 0.044 0.023 DB00166 | ||
| 0.115 | 0.007 | 0.115 | NMDA receptor subunit 3A antagonist | 0.039 0.026 DB01828 | ||
| 0.112 | 0.006 | 0.128 | Glutamate (mGluR7) antagonist | 0.128 0.004 DB01828 | DB01828 | |
| 0.114 | 0.007 | 0.134 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.134 0.004 DB01828 | DB01828 | |
| 0.109 | 0.003 | 0.109 | Membrane dipeptidase inhibitor | 0.06 0.01 DB01828 0.09 0.004 DBMET03082 0.078 0.005 DB00166 | ||
| 0.252 | 0.146 | 0.252 | Immunosuppressant | |||
| 0.112 | 0.006 | 0.112 | Kinesin-like protein 1 inhibitor | 0.033 0.031 DB01828 | ||
| 0.112 | 0.006 | 0.112 | Kinesin antagonist | 0.033 0.031 DB01828 | ||
| 0.121 | 0.017 | 0.121 | Interferon agonist | 0.105 0.025 DB01828 | ||
| 0.11 | 0.005 | 0.11 | Carbonic anhydrase IV inhibitor | 0.039 0.034 DB01828 | ||
| 0.125 | 0.021 | 0.201 | Somatostatin 1 agonist | 0.091 0.041 DB01828 0.105 0.031 DBMET03082 0.201 0.007 DB00166 | DB00166 | |
| 0.116 | 0.012 | 0.118 | Estrogen-related receptor beta agonist | 0.118 0.011 DB01828 | DB01828 | |
| 0.15 | 0.047 | 0.15 | Monophenol monooxygenase inhibitor | 0.093 0.082 DB01828 0.113 0.066 DB00166 | ||
| 0.107 | 0.004 | 0.107 | Glutamate (mGluR1a) agonist | 0.065 0.004 DB01828 0.022 0.015 DB00166 | ||
| 0.113 | 0.011 | 0.113 | Glycine transporter 2 inhibitor | |||
| 0.107 | 0.005 | 0.107 | AMPA 1 receptor antagonist | |||
| 0.137 | 0.035 | 0.149 | Transcription factor STAT6 inhibitor | 0.149 0.024 DB01828 | DB01828 | |
| 0.106 | 0.004 | 0.106 | Dopamine D5 agonist | 0.089 0.005 DB01828 | ||
| 0.125 | 0.025 | 0.192 | CYP2A6 inhibitor | 0.192 0.009 DB01828 | DB01828 | |
| 0.132 | 0.034 | 0.132 | Urease inhibitor | 0.132 0.034 DB01828 0.115 0.05 DBMET03082 | ||
| 0.14 | 0.042 | 0.148 | DNA repair enzyme inhibitor | 0.148 0.033 DB01828 | DB01828 | |
| 0.12 | 0.022 | 0.12 | Selectin antagonist | |||
| 0.163 | 0.065 | 0.223 | Hexokinase inhibitor | 0.16 0.068 DB01828 0.223 0.024 DB00166 | DB00166 | |
| 0.102 | 0.004 | 0.102 | Neuraminidase (Influenza A) inhibitor | |||
| 0.129 | 0.031 | 0.129 | Factor V inhibitor | 0.117 0.042 DB01828 | ||
| 0.137 | 0.039 | 0.137 | Caspase 3 inhibitor | |||
| 0.131 | 0.034 | 0.158 | Sphingomyelinase inhibitor | 0.158 0.021 DB01828 | DB01828 | |
| 0.105 | 0.008 | 0.105 | Sphingosine 1-phosphate receptor 5 agonist | 0.057 0.03 DB00166 | ||
| 0.117 | 0.021 | 0.258 | Peroxisome proliferator-activated receptor gamma agonist | 0.14 0.015 DBMET03082 0.258 0.005 DB00166 | DB00166 | |
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 DB01828 | ||
| 0.11 | 0.014 | 0.11 | Purinergic P2X1 antagonist | 0.099 0.017 DB01828 | ||
| 0.104 | 0.008 | 0.828 | Angiotensin-converting enzyme inhibitor | 0.828 0.001 DBMET03082 0.115 0.007 DB00166 | DBMET03082 | |
| 0.158 | 0.062 | 0.158 | Thiol protease inhibitor | 0.138 0.083 DB01828 0.122 0.113 DB00166 | ||
| 0.137 | 0.041 | 0.137 | TRPA1 agonist | 0.126 0.052 DB01828 | ||
| 0.105 | 0.009 | 0.109 | MAP kinase kinase 7 inhibitor | 0.109 0.007 DB01828 | DB01828 | |
| 0.1 | 0.005 | 0.1 | Retinoid X alpha receptor agonist | 0.031 0.029 DB01828 | ||
| 0.113 | 0.018 | 0.113 | HIV-1 integrase inhibitor | |||
| 0.138 | 0.044 | 0.139 | Microtubule formation inhibitor | 0.139 0.044 DB01828 0.099 0.092 DB00166 | DB01828 | |
| 0.097 | 0.005 | 0.097 | AMPA 2 receptor antagonist | |||
| 0.243 | 0.153 | 0.243 | Toll-Like receptor 7 agonist | |||
| 0.115 | 0.025 | 0.115 | Bile acid receptor antagonist | 0.094 0.063 DB01828 | ||
| 0.11 | 0.021 | 0.11 | Thioredoxin reductase inhibitor | |||
| 0.098 | 0.01 | 0.112 | Exportin-1 inhibitor | 0.112 0.005 DB01828 | DB01828 | |
| 0.092 | 0.004 | 0.092 | AMPA 3 receptor antagonist | 0.026 0.023 DB01828 | ||
| 0.089 | 0.005 | 0.089 | GABA B receptor antagonist | 0.051 0.019 DB01828 | ||
| 0.095 | 0.011 | 0.095 | Nitric oxide donor | |||
| 0.124 | 0.04 | 0.124 | Toll-Like receptor 4 antagonist | |||
| 0.112 | 0.029 | 0.12 | Cathepsin G inhibitor | 0.075 0.048 DB01828 0.12 0.027 DB00166 | DB00166 | |
| 0.206 | 0.124 | 0.292 | 5 Hydroxytryptamine 1E antagonist | 0.292 0.035 DB01828 | DB01828 | |
| 0.092 | 0.01 | 0.092 | Complement C3a chemotactic receptor antagonist | |||
| 0.095 | 0.014 | 0.095 | Interferon inducer | 0.084 0.021 DB01828 | ||
| 0.092 | 0.011 | 0.092 | Glutamate (mGluR group III) agonist | 0.056 0.02 DB01828 | ||
| 0.086 | 0.005 | 0.086 | Kainate receptor 2 antagonist | 0.046 0.018 DB01828 | ||
| 0.098 | 0.018 | 0.098 | Trypsin inhibitor | 0.06 0.048 DB01828 | ||
| 0.112 | 0.032 | 0.112 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.082 0.049 DB01828 | ||
| 0.102 | 0.022 | 0.102 | Sirtuin 1 inhibitor | |||
| 0.108 | 0.028 | 0.108 | NMDA 2 receptor antagonist | |||
| 0.097 | 0.018 | 0.344 | Maillard reaction inhibitor | 0.344 0.003 DB00166 | DB00166 | |
| 0.1 | 0.021 | 0.1 | Ribonucleotide reductase inhibitor | 0.061 0.036 DB01828 0.068 0.032 DBMET03082 0.056 0.038 DB00166 | ||
| 0.09 | 0.01 | 0.09 | CD45 antagonist | |||
| 0.124 | 0.044 | 0.124 | Mediator release inhibitor | |||
| 0.104 | 0.025 | 0.104 | Carbonic anhydrase inhibitor | |||
| 0.087 | 0.009 | 0.087 | DNA helicase inhibitor | 0.052 0.044 DB00166 | ||
| 0.1 | 0.022 | 0.1 | Glucagon-like peptide 1 agonist | 0.092 0.027 DB00166 | ||
| 0.082 | 0.005 | 0.082 | Dopamine beta hydroxylase inhibitor | 0.076 0.005 DB01828 | ||
| 0.091 | 0.015 | 0.091 | Heat shock protein 90 beta antagonist | 0.067 0.031 DB01828 | ||
| 0.105 | 0.029 | 0.111 | Myeloperoxidase inhibitor | 0.111 0.025 DB01828 | DB01828 | |
| 0.095 | 0.02 | 0.095 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DB01828 0.067 0.03 DBMET03082 0.056 0.037 DB00166 | ||
| 0.095 | 0.02 | 0.095 | Carbonic anhydrase I inhibitor | |||
| 0.088 | 0.015 | 0.088 | AMPA receptor antagonist | |||
| 0.078 | 0.005 | 0.078 | Geranyltranstransferase inhibitor | 0.068 0.008 DB01828 | ||
| 0.077 | 0.004 | 0.079 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.079 0.004 DB01828 | DB01828 | |
| 0.08 | 0.008 | 0.08 | Retinoid X receptor agonist | |||
| 0.079 | 0.006 | 0.079 | Dihydropteroate synthase inhibitor | 0.062 0.011 DB01828 | ||
| 0.08 | 0.008 | 0.089 | Thymidylate synthase inhibitor | 0.054 0.023 DB01828 0.089 0.005 DB00166 | DB00166 | |
| 0.081 | 0.008 | 0.081 | Phosphoglycerate kinase inhibitor | 0.052 0.013 DB01828 | ||
| 0.075 | 0.003 | 0.075 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 DB01828 | ||
| 0.081 | 0.009 | 0.081 | Adenosine deaminase inhibitor | 0.068 0.015 DB01828 0.062 0.019 DBMET03082 | ||
| 0.076 | 0.005 | 0.076 | GABA uptake inhibitor | 0.054 0.013 DB01828 | ||
| 0.074 | 0.004 | 0.074 | Glutamate (mGluR8) antagonist | 0.038 0.019 DB01828 0.049 0.009 DB00166 | ||
| 0.074 | 0.004 | 0.074 | Glutamate (mGluR1) agonist | 0.041 0.005 DB01828 | ||
| 0.121 | 0.052 | 0.146 | Protein kinase C gamma inhibitor | 0.146 0.034 DB01828 | DB01828 | |
| 0.084 | 0.015 | 0.084 | Carbonic anhydrase XIV inhibitor | |||
| 0.083 | 0.015 | 0.084 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 DB01828 0.084 0.015 DBMET03082 | DBMET03082 | |
| 0.078 | 0.01 | 0.078 | Adenine nucleotide translocase inhibitor | |||
| 0.096 | 0.028 | 0.096 | Thrombin inhibitor | |||
| 0.077 | 0.009 | 0.084 | Adenylate cyclase 1 inhibitor | 0.084 0.007 DB01828 | DB01828 | |
| 0.089 | 0.022 | 0.089 | Carbonic anhydrase II inhibitor | |||
| 0.179 | 0.112 | 0.228 | Cyclic AMP phosphodiesterase inhibitor | 0.228 0.075 DB01828 0.16 0.136 DB00166 | DB01828 | |
| 0.079 | 0.013 | 0.086 | Epithelial sodium channel blocker | 0.086 0.01 DB01828 | DB01828 | |
| 0.07 | 0.005 | 0.07 | Guanylate cyclase inhibitor | 0.061 0.011 DB01828 | ||
| 0.087 | 0.022 | 0.087 | Plasminogen activator inhibitor | |||
| 0.074 | 0.009 | 0.074 | AICAR transformylase inhibitor | 0.055 0.018 DB01828 0.042 0.033 DB00166 | ||
| 0.081 | 0.017 | 0.081 | Bombesin 2 receptor antagonist | 0.051 0.032 DB01828 | ||
| 0.082 | 0.018 | 0.082 | MDM2 inhibitor | 0.071 0.037 DB01828 | ||
| 0.07 | 0.009 | 0.07 | Integrin alpha5beta1 antagonist | 0.042 0.026 DBMET03082 0.064 0.01 DB00166 | ||
| 0.074 | 0.012 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.025 DB01828 0.052 0.033 DB00166 | ||
| 0.072 | 0.011 | 0.072 | Sphingosine 1-phosphate receptor agonist | |||
| 0.071 | 0.011 | 0.172 | Leukotriene A4 hydrolase inhibitor | 0.172 0.004 DBMET03082 | DBMET03082 | |
| 0.088 | 0.028 | 0.103 | Vanilloid 4 agonist | 0.103 0.015 DB01828 | DB01828 | |
| 0.142 | 0.082 | 0.194 | Acetylcholine M1 receptor antagonist | 0.152 0.073 DB01828 0.194 0.045 DB00166 | DB00166 | |
| 0.125 | 0.066 | 0.125 | Histone deacetylase class III inhibitor | |||
| 0.068 | 0.009 | 0.068 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.062 | 0.004 | 0.062 | Glutamate (mGluR3) agonist | 0.047 0.005 DB01828 0.042 0.008 DB00166 | ||
| 0.072 | 0.013 | 0.072 | Carbonic anhydrase II stimulant | |||
| 0.068 | 0.009 | 0.068 | Carbonic anhydrase I stimulant | |||
| 0.082 | 0.024 | 0.175 | Aminopeptidase microsomal inhibitor | 0.175 0.005 DBMET03082 0.066 0.034 DB00166 | DBMET03082 | |
| 0.079 | 0.022 | 0.079 | Urokinase inhibitor | 0.052 0.032 DB01828 | ||
| 0.059 | 0.002 | 0.059 | Carbonic anhydrase X inhibitor | 0.04 0.003 DB01828 0.027 0.005 DBMET03082 0.023 0.007 DB00166 | ||
| 0.059 | 0.002 | 0.059 | Carbonic anhydrase VIII inhibitor | 0.04 0.003 DB01828 0.027 0.005 DBMET03082 0.023 0.007 DB00166 | ||
| 0.072 | 0.016 | 0.072 | Ryanodine receptor antagonist | 0.067 0.021 DB01828 0.059 0.039 DB00166 | ||
| 0.198 | 0.142 | 0.48 | Lipoxygenase inhibitor | 0.308 0.068 DBMET03082 0.48 0.021 DB00166 | DB00166 | |
| 0.121 | 0.066 | 0.184 | Beta amyloid protein antagonist | 0.123 0.064 DB01828 0.184 0.022 DBMET03082 | DBMET03082 | |
| 0.114 | 0.058 | 0.175 | Falcipain 3 inhibitor | 0.175 0.026 DB01828 | DB01828 | |
| 0.059 | 0.004 | 0.059 | Carboxypeptidase B inhibitor | 0.033 0.022 DB01828 0.046 0.008 DBMET03082 0.039 0.014 DB00166 | ||
| 0.061 | 0.007 | 0.061 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.045 0.01 DB01828 | ||
| 0.077 | 0.024 | 0.077 | Prostaglandin antagonist | |||
| 0.095 | 0.043 | 0.095 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.138 | 0.087 | 0.138 | Heat shock protein 90 antagonist | 0.126 0.103 DB01828 | ||
| 0.126 | 0.076 | 0.357 | NADPH oxidase inhibitor | 0.121 0.082 DB01828 0.357 0.006 DB00166 | DB00166 | |
| 0.055 | 0.005 | 0.055 | Kainate receptor 1 antagonist | |||
| 0.059 | 0.01 | 0.086 | Diamine oxidase inhibitor | 0.086 0.005 DB01828 | DB01828 | |
| 0.069 | 0.02 | 0.079 | Diacylglycerol O-acyltransferase inhibitor | 0.079 0.014 DB00166 | DB00166 | |
| 0.08 | 0.032 | 0.161 | Neutrophil collagenase inhibitor | 0.161 0.011 DBMET03082 | DBMET03082 | |
| 0.181 | 0.133 | 0.397 | Calpain inhibitor | 0.192 0.121 DB01828 0.252 0.062 DBMET03082 0.397 0.009 DB00166 | DB00166 | |
| 0.077 | 0.029 | 0.093 | Protease 3C (Human rhinovirus) inhibitor | 0.093 0.019 DB01828 0.071 0.036 DBMET03082 | DB01828 | |
| 0.058 | 0.011 | 0.116 | VLA-4 antagonist | 0.116 0.005 DB00166 | DB00166 | |
| 0.108 | 0.061 | 0.324 | AMP-activated protein kinase stimulant | 0.324 0.005 DB00166 | DB00166 | |
| 0.061 | 0.014 | 0.089 | Histamine H2 receptor agonist | 0.089 0.005 DB01828 0.039 0.037 DBMET03082 | DB01828 | |
| 0.068 | 0.021 | 0.068 | Phosphorylase inhibitor | |||
| 0.111 | 0.065 | 0.111 | GABA receptor agonist | 0.092 0.087 DB01828 | ||
| 0.076 | 0.03 | 0.076 | Beta adrenoreceptor antagonist | |||
| 0.06 | 0.015 | 0.06 | Calcitonin receptor agonist | 0.033 0.024 DB01828 0.037 0.021 DB00166 | ||
| 0.053 | 0.007 | 0.053 | Uridine phosphorylase inhibitor | 0.042 0.011 DB01828 | ||
| 0.07 | 0.025 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | 0.063 0.034 DB01828 | ||
| 0.138 | 0.092 | 0.508 | Protein-tyrosine phosphatase inhibitor | 0.508 0.005 DB00166 | DB00166 | |
| 0.095 | 0.051 | 0.095 | Phosphodiesterase I inhibitor | |||
| 0.073 | 0.028 | 0.073 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.073 | 0.029 | 0.073 | Caspase 9 inhibitor | |||
| 0.068 | 0.024 | 0.068 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DB01828 | ||
| 0.062 | 0.018 | 0.13 | Macrophage elastase inhibitor | 0.13 0.006 DBMET03082 | DBMET03082 | |
| 0.063 | 0.019 | 0.063 | Heparanase inhibitor | 0.05 0.044 DB00166 | ||
| 0.065 | 0.022 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.091 | 0.048 | 0.112 | Factor XII inhibitor | 0.112 0.028 DBMET03082 | DBMET03082 | |
| 0.192 | 0.148 | 0.315 | MAP kinase kinase 3 inhibitor | 0.315 0.005 DB01828 | DB01828 | |
| 0.048 | 0.005 | 0.048 | Calcium-sensing receptor agonist | |||
| 0.064 | 0.021 | 0.064 | Beta 2 adrenoreceptor antagonist | |||
| 0.064 | 0.022 | 0.068 | Leukotriene C antagonist | 0.068 0.016 DB00166 | DB00166 | |
| 0.046 | 0.004 | 0.049 | Purinergic P2Y15 antagonist | 0.049 0.004 DB01828 | DB01828 | |
| 0.059 | 0.018 | 0.063 | Oxytocin agonist | 0.063 0.014 DB01828 0.058 0.018 DBMET03082 0.056 0.02 DB00166 | DB01828 | |
| 0.149 | 0.108 | 0.149 | Catenin beta inhibitor | |||
| 0.045 | 0.004 | 0.045 | Lysophosphatidic acid receptor 1 agonist | 0.031 0.01 DB01828 0.027 0.014 DB00166 | ||
| 0.064 | 0.023 | 0.075 | Thromboxane synthase inhibitor | 0.075 0.014 DB00166 | DB00166 | |
| 0.045 | 0.005 | 0.045 | Thyroid hormone agonist | |||
| 0.103 | 0.063 | 0.103 | Protease inhibitor | |||
| 0.088 | 0.048 | 0.088 | Adrenaline agonist | |||
| 0.041 | 0.002 | 0.041 | Glutamate (mGluR6) agonist | 0.022 0.004 DB01828 0.019 0.004 DB00166 | ||
| 0.048 | 0.01 | 0.048 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DB01828 | ||
| 0.05 | 0.012 | 0.05 | Trypsin I inhibitor | |||
| 0.053 | 0.015 | 0.073 | Histamine H1 receptor agonist | 0.073 0.004 DB01828 | DB01828 | |
| 0.045 | 0.007 | 0.045 | Vitronectin receptor antagonist | 0.024 0.013 DB00166 | ||
| 0.048 | 0.01 | 0.048 | VCAM-1 antagonist | |||
| 0.048 | 0.01 | 0.048 | VCAM antagonist | |||
| 0.097 | 0.06 | 0.134 | MAP kinase kinase 1 inhibitor | 0.134 0.024 DB01828 | DB01828 | |
| 0.053 | 0.017 | 0.053 | Thymidine kinase inhibitor | 0.045 0.023 DB01828 | ||
| 0.081 | 0.044 | 0.081 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.098 | 0.062 | 0.098 | Xanthine oxidase inhibitor | |||
| 0.061 | 0.024 | 0.156 | Aminopeptidase N inhibitor | 0.156 0.005 DBMET03082 0.048 0.033 DB00166 | DBMET03082 | |
| 0.06 | 0.024 | 0.081 | Immunoglobulin Fc receptor antagonist | 0.081 0.005 DB01828 0.07 0.011 DBMET03082 | DB01828 | |
| 0.067 | 0.032 | 0.077 | Histone deacetylase SIRT3 inhibitor | 0.077 0.021 DB01828 | DB01828 | |
| 0.083 | 0.048 | 0.083 | Macrophage migration inhibitory factor inhibitor | |||
| 0.137 | 0.102 | 0.137 | Heat shock protein 90 alpha antagonist | 0.134 0.105 DB01828 | ||
| 0.084 | 0.049 | 0.135 | Metalloproteinase-2 inhibitor | 0.135 0.023 DBMET03082 0.074 0.06 DB00166 | DBMET03082 | |
| 0.049 | 0.014 | 0.049 | Retinoid X receptor antagonist | |||
| 0.059 | 0.024 | 0.059 | Plasminogen activator inhibitor antagonist | |||
| 0.051 | 0.016 | 0.083 | Alpha 1d adrenoreceptor agonist | 0.083 0.005 DB01828 | DB01828 | |
| 0.048 | 0.013 | 0.048 | Integrin alpha2 antagonist | 0.039 0.023 DB01828 | ||
| 0.039 | 0.005 | 0.039 | Integrin alphaVbeta3 antagonist | 0.02 0.017 DB00166 | ||
| 0.066 | 0.033 | 0.066 | Glutamate (mGluR1) antagonist | 0.065 0.035 DB01828 | ||
| 0.087 | 0.054 | 0.087 | Vanilloid agonist | |||
| 0.054 | 0.021 | 0.064 | Cytokine production stimulant | 0.064 0.01 DB01828 | DB01828 | |
| 0.167 | 0.135 | 0.398 | Vasodilator | 0.398 0.024 DB00166 | DB00166 | |
| 0.093 | 0.061 | 0.109 | Protein kinase C zeta inhibitor | 0.109 0.041 DB01828 | DB01828 | |
| 0.061 | 0.03 | 0.083 | Sphingosine kinase 2 inhibitor | 0.083 0.014 DB01828 | DB01828 | |
| 0.04 | 0.008 | 0.062 | LFA antagonist | 0.062 0.005 DB00166 | DB00166 | |
| 0.036 | 0.005 | 0.042 | Vanilloid 2 agonist | 0.042 0.004 DB01828 0.024 0.021 DB00166 | DB01828 | |
| 0.043 | 0.012 | 0.043 | Retinoid X alpha receptor antagonist | |||
| 0.054 | 0.024 | 0.131 | Collagenase inhibitor | 0.131 0.004 DBMET03082 | DBMET03082 | |
| 0.044 | 0.013 | 0.044 | Glutamate (mGluR4) agonist | 0.036 0.02 DB01828 | ||
| 0.06 | 0.03 | 0.064 | Pregnane X receptor antagonist | 0.064 0.022 DB01828 | DB01828 | |
| 0.103 | 0.073 | 0.103 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.138 | 0.109 | 0.138 | Antipruritic | 0.13 0.123 DB01828 | ||
| 0.042 | 0.013 | 0.066 | Peptide deformylase inhibitor | 0.032 0.02 DB01828 0.066 0.006 DBMET03082 | DBMET03082 | |
| 0.034 | 0.005 | 0.067 | Aminopeptidase A inhibitor | 0.019 0.011 DB01828 0.067 0.003 DBMET03082 0.028 0.007 DB00166 | DBMET03082 | |
| 0.042 | 0.013 | 0.042 | Dipeptidyl peptidase II inhibitor | 0.038 0.016 DB01828 | ||
| 0.15 | 0.121 | 0.25 | MAP kinase kinase 2 inhibitor | 0.25 0.054 DB01828 | DB01828 | |
| 0.117 | 0.089 | 0.117 | Alkaline phosphatase inhibitor | |||
| 0.036 | 0.008 | 0.073 | Integrin beta3 antagonist | 0.073 0.005 DB00166 | DB00166 | |
| 0.073 | 0.046 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.043 | 0.016 | 0.065 | Somatostatin 5 agonist | 0.065 0.008 DB00166 | DB00166 | |
| 0.032 | 0.005 | 0.032 | ICAM 1 antagonist | 0.025 0.011 DB01828 | ||
| 0.072 | 0.044 | 0.084 | Protein kinase C beta inhibitor | 0.084 0.025 DB01828 | DB01828 | |
| 0.043 | 0.016 | 0.043 | Integrin alpha1beta1 antagonist | |||
| 0.059 | 0.033 | 0.085 | Thromboxane antagonist | 0.085 0.017 DB00166 | DB00166 | |
| 0.035 | 0.009 | 0.035 | Prostaglandin H2 antagonist | 0.034 0.009 DB00166 | ||
| 0.043 | 0.017 | 0.147 | Somatostatin 5 antagonist | 0.147 0.005 DB00166 | DB00166 | |
| 0.063 | 0.037 | 0.101 | Potassium channel intermediate-conductance Ca-activated blocker | 0.101 0.009 DB01828 | DB01828 | |
| 0.044 | 0.018 | 0.044 | Antibiotic Aminoglycoside-like | 0.044 0.017 DB01828 | ||
| 0.115 | 0.089 | 0.125 | Antibacterial (Helicobacter pylori) | 0.125 0.073 DB01828 | DB01828 | |
| 0.03 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 DB01828 | ||
| 0.064 | 0.038 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | 0.08 0.017 DB01828 | DB01828 | |
| 0.056 | 0.031 | 0.056 | Dipeptidyl peptidase inhibitor | 0.054 0.035 DB01828 | ||
| 0.036 | 0.011 | 0.036 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.034 | 0.009 | 0.034 | Integrin alpha2beta1 antagonist | 0.029 0.014 DB01828 | ||
| 0.047 | 0.022 | 0.062 | Nerve growth factor antagonist | 0.062 0.008 DB01828 | DB01828 | |
| 0.056 | 0.032 | 0.081 | Thromboxane A2 antagonist | 0.081 0.014 DB00166 | DB00166 | |
| 0.046 | 0.022 | 0.148 | Somatostatin 1 antagonist | 0.148 0.005 DB00166 | DB00166 | |
| 0.047 | 0.023 | 0.047 | Dihydrofolate reductase inhibitor | 0.046 0.025 DB01828 | ||
| 0.155 | 0.132 | 0.178 | Histone acetyltransferase inhibitor | 0.178 0.102 DB01828 | DB01828 | |
| 0.04 | 0.017 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 DB01828 | ||
| 0.057 | 0.034 | 0.066 | Dihydroorotate oxidase inhibitor | 0.066 0.021 DB01828 | DB01828 | |
| 0.028 | 0.005 | 0.028 | Retinoid X beta receptor antagonist | |||
| 0.027 | 0.004 | 0.027 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.042 | 0.02 | 0.042 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.026 | 0.004 | 0.026 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DB01828 0.02 0.009 DB00166 | ||
| 0.052 | 0.03 | 0.066 | Topoisomerase II beta inhibitor | 0.066 0.018 DB01828 | DB01828 | |
| 0.03 | 0.009 | 0.053 | Prostaglandin F2 alpha agonist | 0.053 0.004 DB00166 | DB00166 | |
| 0.073 | 0.051 | 0.223 | Metalloproteinase-9 inhibitor | 0.223 0.007 DBMET03082 | DBMET03082 | |
| 0.043 | 0.021 | 0.049 | Cholecystokinin B agonist | 0.049 0.016 DB00166 | DB00166 | |
| 0.061 | 0.04 | 0.106 | Prostaglandin EP2 antagonist | 0.106 0.017 DB00166 | DB00166 | |
| 0.243 | 0.222 | 0.509 | Apoptosis agonist | 0.509 0.072 DBMET03082 0.255 0.209 DB00166 | DBMET03082 | |
| 0.06 | 0.039 | 0.06 | Cyclin A1 inhibitor | 0.056 0.046 DB01828 | ||
| 0.045 | 0.024 | 0.045 | Neurokinin 2 agonist | 0.037 0.035 DBMET03082 | ||
| 0.025 | 0.004 | 0.025 | Telomerase stimulant | 0.025 0.004 DB01828 | ||
| 0.064 | 0.043 | 0.106 | 5 Hydroxytryptamine 3 agonist | 0.106 0.013 DB01828 | DB01828 | |
| 0.028 | 0.007 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 DB01828 | DB01828 | |
| 0.025 | 0.004 | 0.025 | Lysophosphatidic acid receptor 3 agonist | 0.019 0.006 DB01828 | ||
| 0.06 | 0.039 | 0.07 | Sphingosine kinase inhibitor | 0.07 0.025 DB01828 | DB01828 | |
| 0.032 | 0.012 | 0.034 | Prostaglandin EP2 agonist | 0.034 0.011 DB00166 | DB00166 | |
| 0.036 | 0.016 | 0.055 | Endothelial nitric-oxide synthase inhibitor | 0.055 0.008 DB01828 | DB01828 | |
| 0.045 | 0.025 | 0.045 | Angiotensin AT1 receptor antagonist | 0.038 0.037 DB00166 | ||
| 0.051 | 0.032 | 0.051 | Factor III inhibitor | |||
| 0.051 | 0.031 | 0.051 | HCV NS3/NS4A protease inhibitor | 0.048 0.035 DB01828 | ||
| 0.033 | 0.013 | 0.065 | Urotensin II agonist | 0.025 0.022 DB01828 0.065 0.004 DB00166 | DB00166 | |
| 0.041 | 0.022 | 0.046 | Leukotriene C4 antagonist | 0.046 0.014 DB00166 | DB00166 | |
| 0.055 | 0.035 | 0.055 | Leukotriene B4 antagonist | |||
| 0.033 | 0.015 | 0.096 | Integrin alpha4 antagonist | 0.096 0.006 DB00166 | DB00166 | |
| 0.057 | 0.039 | 0.057 | Beta 1 adrenoreceptor antagonist | |||
| 0.027 | 0.01 | 0.06 | Integrin beta5 antagonist | 0.06 0.005 DB00166 | DB00166 | |
| 0.082 | 0.064 | 0.119 | mTOR complex 2 inhibitor | 0.119 0.018 DB01828 | DB01828 | |
| 0.022 | 0.005 | 0.027 | Thromboxane A2 agonist | 0.015 0.013 DB01828 0.027 0.004 DB00166 | DB00166 | |
| 0.025 | 0.007 | 0.026 | Prostacyclin agonist | 0.026 0.007 DB00166 | DB00166 | |
| 0.062 | 0.045 | 0.089 | 5 Hydroxytryptamine 2A agonist | 0.089 0.02 DB01828 | DB01828 | |
| 0.046 | 0.028 | 0.046 | Beta adrenoreceptor agonist | |||
| 0.156 | 0.138 | 0.892 | Free radical scavenger | 0.859 0.004 DBMET03082 0.892 0.003 DB00166 | DB00166 | |
| 0.034 | 0.017 | 0.034 | Glucagon receptor antagonist | |||
| 0.024 | 0.007 | 0.024 | Toll-Like receptor 8 agonist | 0.021 0.013 DB01828 | ||
| 0.038 | 0.021 | 0.038 | AMPA receptor agonist | 0.037 0.022 DBMET03082 | ||
| 0.036 | 0.02 | 0.042 | Sirtuin 2 inhibitor | 0.042 0.016 DB01828 | DB01828 | |
| 0.021 | 0.004 | 0.021 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DB01828 | ||
| 0.03 | 0.013 | 0.03 | Retinoid X gamma receptor antagonist | |||
| 0.049 | 0.032 | 0.049 | Plasmin inhibitor | |||
| 0.031 | 0.015 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 DB01828 | DB01828 | |
| 0.065 | 0.049 | 0.228 | Matrix metalloproteinase inhibitor | 0.228 0.007 DBMET03082 | DBMET03082 | |
| 0.022 | 0.008 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 DB01828 | DB01828 | |
| 0.039 | 0.025 | 0.039 | Farnesoid X receptor agonist | |||
| 0.042 | 0.028 | 0.042 | Cholecystokinin antagonist | |||
| 0.033 | 0.018 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.018 | 0.005 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DB01828 | DB01828 | |
| 0.018 | 0.005 | 0.018 | Egl nine homolog 3 inhibitor | |||
| 0.033 | 0.02 | 0.038 | Methionyl aminopeptidase 1 inhibitor | 0.038 0.014 DB01828 | DB01828 | |
| 0.053 | 0.04 | 0.162 | Matrix metalloproteinase (membrane-type) inhibitor | 0.162 0.008 DBMET03082 0.051 0.044 DB00166 | DBMET03082 | |
| 0.026 | 0.013 | 0.026 | Retinoid X gamma receptor agonist | |||
| 0.078 | 0.065 | 0.114 | Calcium antagonist | 0.114 0.039 DB01828 | DB01828 | |
| 0.138 | 0.125 | 0.188 | 3C-like protease (Human coronavirus) inhibitor | 0.188 0.059 DB01828 | DB01828 | |
| 0.039 | 0.026 | 0.063 | Vascular adhesion protein 1 inhibitor | 0.063 0.008 DB01828 | DB01828 | |
| 0.042 | 0.029 | 0.077 | Growth hormone release inhibitor | 0.077 0.01 DBMET03082 0.058 0.017 DB00166 | DBMET03082 | |
| 0.035 | 0.022 | 0.035 | Free fatty acid receptor 1 antagonist | |||
| 0.019 | 0.006 | 0.019 | Egl nine homolog 1 inhibitor | |||
| 0.029 | 0.017 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET03082 | ||
| 0.021 | 0.008 | 0.021 | Ileal bile acid transport inhibitor | 0.015 0.014 DB00166 | ||
| 0.054 | 0.042 | 0.054 | Xanthine dehydrogenase inhibitor | |||
| 0.017 | 0.005 | 0.017 | Carboxypeptidase B2 inhibitor | 0.012 0.007 DBMET03082 | ||
| 0.027 | 0.015 | 0.027 | NMDA receptor glycine site antagonist | |||
| 0.032 | 0.021 | 0.035 | ATP citrate lysase inhibitor | 0.035 0.017 DB00166 | DB00166 | |
| 0.026 | 0.015 | 0.037 | Complement factor 1s inhibitor | 0.037 0.004 DB01828 | DB01828 | |
| 0.035 | 0.023 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.031 | 0.02 | 0.056 | Prostaglandin agonist | 0.056 0.009 DB00166 | DB00166 | |
| 0.028 | 0.017 | 0.04 | Hedgehog signaling activator | 0.04 0.004 DB01828 | DB01828 | |
| 0.149 | 0.138 | 0.628 | Hypolipemic | 0.628 0.005 DB00166 | DB00166 | |
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha agonist | |||
| 0.034 | 0.024 | 0.034 | Angiotensin II receptor antagonist | |||
| 0.062 | 0.051 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.06 0.057 DB01828 | ||
| 0.018 | 0.008 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 DB01828 | DB01828 | |
| 0.021 | 0.011 | 0.021 | Integrin alphaVbeta1 antagonist | |||
| 0.037 | 0.028 | 0.037 | Glutamate (mGluR group II) antagonist | 0.035 0.032 DB01828 | ||
| 0.036 | 0.027 | 0.036 | Tryptase inhibitor | |||
| 0.048 | 0.039 | 0.068 | Squalene epoxidase inhibitor | 0.068 0.015 DB01828 | DB01828 | |
| 0.027 | 0.018 | 0.027 | Nicotinic acid receptor 2 antagonist | 0.027 0.018 DB01828 | ||
| 0.037 | 0.028 | 0.037 | DNA gyrase subunit B inhibitor | |||
| 0.123 | 0.115 | 0.137 | Neuropeptide Y1 antagonist | 0.137 0.086 DB01828 | DB01828 | |
| 0.055 | 0.046 | 0.055 | CXC chemokine 4 receptor antagonist | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin D2 antagonist | |||
| 0.038 | 0.03 | 0.062 | Glucagon-like peptide 1 receptor antagonist | 0.062 0.008 DB00166 | DB00166 | |
| 0.022 | 0.014 | 0.022 | Integrin alpha4beta7 antagonist | 0.021 0.014 DB00166 | ||
| 0.027 | 0.019 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 DB01828 | DB01828 | |
| 0.026 | 0.018 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DB01828 | DB01828 | |
| 0.042 | 0.035 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | 0.051 0.023 DB01828 | DB01828 | |
| 0.021 | 0.013 | 0.056 | Integrin beta7 antagonist | 0.056 0.005 DB00166 | DB00166 | |
| 0.029 | 0.022 | 0.029 | Cholecystokinin B antagonist | |||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | |||
| 0.041 | 0.035 | 0.041 | Purinergic P2Y antagonist | |||
| 0.02 | 0.013 | 0.02 | Caspase 8 inhibitor | 0.018 0.016 DB00166 | ||
| 0.028 | 0.021 | 0.028 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.031 | 0.025 | 0.031 | Prostacyclin antagonist | |||
| 0.098 | 0.092 | 0.138 | Acetylcholine release stimulant | 0.138 0.026 DB01828 | DB01828 | |
| 0.01 | 0.003 | 0.01 | Integrin alpha5beta6 antagonist | |||
| 0.033 | 0.027 | 0.033 | p53 inhibitor | |||
| 0.015 | 0.009 | 0.015 | Integrin alphaVbeta6 antagonist | |||
| 0.013 | 0.007 | 0.013 | Egl nine homolog 2 inhibitor | |||
| 0.021 | 0.015 | 0.021 | Retinoid X beta receptor agonist | |||
| 0.043 | 0.037 | 0.043 | Glycine transporter inhibitor | |||
| 0.035 | 0.029 | 0.035 | Factor XIIIa inhibitor | |||
| 0.015 | 0.01 | 0.015 | CXC chemokine 4 receptor agonist | 0.015 0.01 DB01828 | ||
| 0.028 | 0.023 | 0.028 | Trypsin II inhibitor | |||
| 0.091 | 0.086 | 0.091 | Protein kinase (CK2) alpha inhibitor | |||
| 0.01 | 0.005 | 0.01 | Thyroid hormone beta agonist | |||
| 0.043 | 0.038 | 0.043 | Parathyroid hormone antagonist | |||
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.017 | 0.013 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 DB01828 | DB01828 | |
| 0.018 | 0.015 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 DB01828 | DB01828 | |
| 0.082 | 0.079 | 0.082 | Uric acid excretion stimulant | |||
| 0.078 | 0.075 | 0.129 | Transcription factor NF kappa B stimulant | 0.129 0.021 DB00166 | DB00166 | |
| 0.025 | 0.022 | 0.147 | Somatostatin 2 antagonist | 0.147 0.005 DB00166 | DB00166 | |
| 0.016 | 0.013 | 0.016 | Kainate receptor 3 antagonist | |||
| 0.042 | 0.039 | 0.042 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.01 | 0.008 | 0.017 | Thromboxane agonist | 0.017 0.004 DB00166 | DB00166 | |
| 0.025 | 0.023 | 0.025 | Bradykinin B2 receptor agonist | |||
| 0.026 | 0.024 | 0.027 | Thrombin receptor antagonist | 0.027 0.022 DB01828 | DB01828 | |
| 0.013 | 0.011 | 0.24 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.24 0.003 DBMET03082 0.041 0.004 DB00166 | DBMET03082 | |
| 0.009 | 0.007 | 0.009 | Integrin alphaVbeta5 antagonist | |||
| 0.021 | 0.019 | 0.029 | Prostaglandin E2 agonist | 0.029 0.011 DB00166 | DB00166 | |
| 0.016 | 0.015 | 0.027 | Cyclin T1 inhibitor | 0.027 0.006 DB01828 | DB01828 | |
| 0.018 | 0.017 | 0.704 | Neutral endopeptidase inhibitor | 0.704 0.001 DBMET03082 | DBMET03082 | |
| 0.018 | 0.017 | 0.018 | Kainate receptor 5 antagonist | |||
| 0.017 | 0.016 | 0.021 | Complement factor D inhibitor | 0.021 0.007 DB01828 | DB01828 | |
| 0.014 | 0.013 | 0.014 | Thyroid hormone alpha antagonist | |||
| 0.056 | 0.055 | 0.099 | Prostaglandin F2 alpha antagonist | 0.099 0.012 DB00166 | DB00166 | |
| 0.02 | 0.02 | 0.046 | Aminopeptidase P inhibitor | 0.046 0.004 DBMET03082 | DBMET03082 | |
| 0.028 | 0.027 | 0.028 | HCV NS5B polymerase inhibitor | |||
| 0.043 | 0.043 | 0.052 | Metalloproteinase-3 inhibitor | 0.052 0.031 DBMET03082 | DBMET03082 | |
| 0.021 | 0.021 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 DB01828 | DB01828 | |
| 0.075 | 0.075 | 0.079 | Caspase 7 inhibitor | 0.079 0.063 DB01828 | DB01828 | |
| 0.039 | 0.039 | 0.457 | Endothelin-converting enzyme inhibitor | 0.457 0.002 DBMET03082 | DBMET03082 | |
| 0.015 | 0.016 | 0.344 | Angiotensin-converting enzyme 2 inhibitor | 0.344 0.002 DBMET03082 | DBMET03082 | |
| 0.056 | 0.057 | 0.075 | Leukotriene antagonist | 0.075 0.036 DB00166 | DB00166 | |
| 0.052 | 0.053 | 0.054 | Androgen agonist | 0.054 0.05 DB01828 | DB01828 | |
| 0.02 | 0.021 | 0.12 | Somatostatin 4 antagonist | 0.12 0.004 DB00166 | DB00166 | |
| 0.006 | 0.008 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.004 DB00166 | DB00166 | |
| 0.03 | 0.032 | 0.04 | Protein kinase (CK2) beta inhibitor | 0.04 0.012 DB01828 | DB01828 | |
| 0.01 | 0.013 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DB00166 | DB00166 | |
| 0.018 | 0.022 | 0.023 | Factor XIII inhibitor | 0.023 0.009 DB01828 | DB01828 | |
| 0.051 | 0.055 | 0.167 | Collagenase 3 inhibitor | 0.167 0.007 DBMET03082 | DBMET03082 | |
| 0.011 | 0.015 | 0.02 | Adenosine A2a receptor agonist | 0.02 0.008 DB00166 | DB00166 | |
| 0.026 | 0.03 | 0.047 | Prostaglandin D2 agonist | 0.047 0.009 DB00166 | DB00166 | |
| 0.029 | 0.034 | 0.036 | Melatonin receptor 1A agonist | 0.036 0.018 DB01828 | DB01828 | |
| 0.02 | 0.025 | 0.022 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 DB01828 | DB01828 | |
| 0.04 | 0.045 | 0.045 | Dipeptidyl peptidase IV inhibitor | 0.045 0.028 DB01828 | DB01828 | |
| 0.013 | 0.018 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.011 DB00166 | DB00166 | |
| 0.036 | 0.042 | 0.046 | Sphingosine kinase 1 inhibitor | 0.046 0.021 DB01828 | DB01828 | |
| 0.019 | 0.026 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 DB01828 | DB01828 | |
| 0.133 | 0.14 | 0.218 | I kappa B kinase epsilon inhibitor | 0.218 0.056 DB01828 | DB01828 | |
| 0.018 | 0.025 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 DB01828 | DB01828 | |
| 0.057 | 0.065 | 0.075 | Transcription factor RelA inhibitor | 0.075 0.023 DB01828 | DB01828 | |
| 0.054 | 0.061 | 0.066 | I kappa B kinase 2 inhibitor | 0.066 0.037 DB01828 | DB01828 | |
| 0.049 | 0.057 | 0.055 | Kallikrein 1 inhibitor | 0.055 0.041 DB01828 | DB01828 | |
| 0.045 | 0.053 | 0.056 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.056 0.034 DB01828 | DB01828 | |
| 0.025 | 0.034 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.025 DB01828 | DB01828 | |
| 0.025 | 0.033 | 0.054 | Vasopressin 1A agonist | 0.054 0.003 DB00166 | DB00166 | |
| 0.038 | 0.047 | 0.145 | Matrix metalloproteinase 1 inhibitor | 0.145 0.007 DBMET03082 | DBMET03082 | |
| 0.023 | 0.032 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 DB01828 | DB01828 | |
| 0.03 | 0.039 | 0.034 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.026 DBMET03082 | DBMET03082 | |
| 0.039 | 0.049 | 0.044 | Heme oxygenase inhibitor | 0.044 0.027 DB01828 | DB01828 | |
| 0.058 | 0.068 | 0.072 | Calcium channel P-type blocker | 0.072 0.025 DB01828 | DB01828 | |
| 0.015 | 0.025 | 0.033 | Growth hormone releasing factor antagonist | 0.033 0.012 DB00166 | DB00166 | |
| 0.1 | 0.111 | 0.146 | Nav1.2 sodium channel blocker | 0.146 0.059 DB01828 | DB01828 | |
| 0.005 | 0.016 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DB01828 | DB01828 | |
| 0.025 | 0.036 | 0.032 | MAP3K8 inhibitor | 0.032 0.014 DB01828 | DB01828 | |
| 0.012 | 0.024 | 0.026 | Alpha 2a adrenoreceptor agonist | 0.026 0.006 DB01828 | DB01828 | |
| 0.127 | 0.139 | 0.152 | Pyruvate kinase inhibitor | 0.152 0.113 DB01828 | DB01828 | |
| 0.027 | 0.039 | 0.191 | Nicotinic acid receptor agonist | 0.191 0.003 DB00166 | DB00166 | |
| 0.016 | 0.028 | 0.021 | Geranylgeranyltransferase inhibitor | 0.021 0.017 DBMET03082 | DBMET03082 | |
| 0.075 | 0.088 | 0.097 | CC chemokine 5 receptor agonist | 0.097 0.026 DB01828 | DB01828 | |
| 0.032 | 0.047 | 0.055 | 5 Hydroxytryptamine 2B agonist | 0.055 0.01 DB01828 | DB01828 | |
| 0.007 | 0.023 | 0.05 | Prostaglandin EP4 agonist | 0.05 0.005 DB00166 | DB00166 | |
| 0.006 | 0.021 | 0.01 | Angiotensin AT2 receptor agonist | 0.01 0.008 DB01828 | DB01828 | |
| 0.03 | 0.046 | 0.043 | Adenosine uptake inhibitor | 0.043 0.008 DB01828 | DB01828 | |
| 0.037 | 0.054 | 0.101 | Neuropeptide agonist | 0.101 0.027 DBMET03082 | DBMET03082 | |
| 0.088 | 0.105 | 0.102 | Acetylcholine muscarinic antagonist | 0.102 0.089 DB01828 | DB01828 | |
| 0.023 | 0.04 | 0.038 | 5 Hydroxytryptamine 6 agonist | 0.038 0.009 DB01828 | DB01828 | |
| 0.119 | 0.137 | 0.143 | MAP kinase 3 inhibitor | 0.143 0.079 DB01828 | DB01828 | |
| 0.016 | 0.034 | 0.04 | Vasopressin 1 agonist | 0.04 0.004 DB00166 | DB00166 | |
| 0.118 | 0.136 | 0.143 | Pregnane X receptor agonist | 0.143 0.067 DB01828 | DB01828 | |
| 0.044 | 0.062 | 0.16 | Vanilloid 2 antagonist | 0.16 0.003 DBMET03082 | DBMET03082 | |
| 0.087 | 0.106 | 0.208 | Proteasome inhibitor | 0.208 0.023 DB00166 | DB00166 | |
| 0.069 | 0.09 | 0.101 | Histamine H2 receptor antagonist | 0.101 0.034 DB01828 | DB01828 | |
| 0.103 | 0.124 | 0.141 | Cytidine deaminase inhibitor | 0.141 0.082 DB01828 | DB01828 | |
| 0.012 | 0.035 | 0.019 | Adenosine kinase inhibitor | 0.019 0.017 DB01828 | DB01828 | |
| 0.061 | 0.085 | 0.082 | Acetylcholine nicotinic antagonist | 0.082 0.053 DB01828 | DB01828 | |
| 0.012 | 0.036 | 0.069 | Somatostatin 3 antagonist | 0.069 0.005 DB00166 | DB00166 | |
| 0.003 | 0.027 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.004 DB01828 | DB01828 | |
| 0.012 | 0.038 | 0.021 | Antibiotic Tetracycline-like | 0.021 0.004 DB01828 | DB01828 | |
| 0.019 | 0.046 | 0.029 | Acid ceramidase inhibitor | 0.029 0.011 DB01828 | DB01828 | |
| 0.046 | 0.073 | 0.165 | HIV-1 integrase (3'-Processing) inhibitor | 0.165 0.012 DB00166 | DB00166 | |
| 0.043 | 0.07 | 0.05 | Glucosylceramidase inhibitor | 0.05 0.048 DB01828 | DB01828 | |
| 0.008 | 0.036 | 0.034 | Free fatty acid receptor 1 agonist | 0.034 0.005 DB00166 | DB00166 | |
| 0.028 | 0.057 | 0.052 | Glutamate (mGluR1a) antagonist | 0.052 0.019 DB01828 | DB01828 | |
| 0.097 | 0.128 | 0.165 | Nav1.6 sodium channel blocker | 0.165 0.039 DB01828 | DB01828 | |
| 0.191 | 0.223 | 0.627 | 15-Lipoxygenase inhibitor | 0.627 0.02 DB00166 | DB00166 | |
| 0.014 | 0.047 | 0.025 | Leukotriene B4 receptor 1 antagonist | 0.025 0.022 DB00166 | DB00166 | |
| 0.01 | 0.043 | 0.026 | Histamine H4 receptor agonist | 0.026 0.008 DB01828 | DB01828 | |
| 0.012 | 0.046 | 0.029 | Imidazoline I1 receptor antagonist | 0.029 0.008 DB01828 | DB01828 | |
| 0.035 | 0.07 | 0.048 | Aldosterone antagonist | 0.048 0.032 DB01828 | DB01828 | |
| 0.036 | 0.072 | 0.073 | Histamine agonist | 0.073 0.017 DB01828 | DB01828 | |
| 0.019 | 0.055 | 0.108 | Antidiuretic hormone agonist | 0.108 0.004 DB00166 | DB00166 | |
| 0.061 | 0.098 | 0.082 | I kappa B kinase inhibitor | 0.082 0.058 DB01828 | DB01828 | |
| 0.019 | 0.056 | 0.03 | Myristoyl transferase inhibitor | 0.03 0.014 DB01828 | DB01828 | |
| 0.032 | 0.072 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.029 DB01828 | DB01828 | |
| 0.071 | 0.111 | 0.098 | Polo-like kinase-1 inhibitor | 0.098 0.049 DB01828 | DB01828 | |
| 0.028 | 0.069 | 0.045 | Glutamate (mGluR group I) agonist | 0.045 0.037 DB01828 | DB01828 | |
| 0.013 | 0.057 | 0.03 | Protease (Human cytomegalovirus) inhibitor | 0.03 0.008 DB01828 | DB01828 | |
| 0.051 | 0.098 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.034 DB01828 | DB01828 | |
| 0.014 | 0.06 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.041 0.007 DB01828 | DB01828 | |
| 0.015 | 0.063 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.01 DB01828 | DB01828 | |
| 0.007 | 0.056 | 0.02 | NMDA receptor phencyclidine site antagonist | 0.02 0.007 DB01828 | DB01828 | |
| 0.042 | 0.093 | 0.068 | Neuronal nicotinic receptor antagonist | 0.068 0.047 DB01828 | DB01828 | |
| 0.051 | 0.103 | 0.085 | Secretase beta inhibitor | 0.085 0.03 DB01828 | DB01828 | |
| 0.048 | 0.101 | 0.355 | Topoisomerase II alpha inhibitor | 0.355 0.005 DBMET03082 0.316 0.006 DB00166 | DBMET03082 | |
| 0.069 | 0.122 | 0.528 | Protein-tyrosine phosphatase 1B inhibitor | 0.528 0.004 DB00166 | DB00166 | |
| 0.04 | 0.094 | 0.065 | 5 Hydroxytryptamine 7 agonist | 0.065 0.024 DB01828 | DB01828 | |
| 0.008 | 0.061 | 0.018 | Nicotinic alpha4 receptor agonist | 0.018 0.009 DB01828 | DB01828 | |
| 0.031 | 0.085 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.03 DB01828 | DB01828 | |
| 0.037 | 0.091 | 0.064 | Acetylcholine M5 receptor antagonist | 0.064 0.037 DB01828 | DB01828 | |
| 0.004 | 0.06 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 DB01828 | DB01828 | |
| 0.011 | 0.067 | 0.036 | 5 Hydroxytryptamine 1D agonist | 0.036 0.016 DB01828 | DB01828 | |
| 0.075 | 0.131 | 0.097 | Phosphodiesterase 6D inhibitor | 0.097 0.058 DB01828 | DB01828 | |
| 0.035 | 0.092 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | 0.053 0.039 DB01828 | DB01828 | |
| 0.032 | 0.09 | 0.047 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.045 DB01828 | DB01828 | |
| 0.1 | 0.159 | 0.174 | Cyclin-dependent kinase 8 inhibitor | 0.174 0.057 DB01828 | DB01828 | |
| 0.006 | 0.067 | 0.017 | Sodium/hydrogen exchanger inhibitor | 0.017 0.012 DB01828 | DB01828 | |
| 0.035 | 0.096 | 0.065 | Cyclin-dependent kinase 6 inhibitor | 0.065 0.036 DB01828 | DB01828 | |
| 0.037 | 0.099 | 0.069 | Cyclin D1 inhibitor | 0.069 0.03 DB01828 | DB01828 | |
| 0.015 | 0.078 | 0.091 | Vasopressin 2 antagonist | 0.091 0.007 DB00166 | DB00166 | |
| 0.019 | 0.084 | 0.029 | Glucosylceramidase stimulant | 0.029 0.014 DB01828 | DB01828 | |
| 0.018 | 0.084 | 0.053 | Nicotinic receptor beta4 subunit antagonist | 0.053 0.014 DB00166 | DB00166 | |
| 0.117 | 0.183 | 0.487 | Platelet aggregation inhibitor | 0.487 0.01 DB00166 | DB00166 | |
| 0.051 | 0.117 | 0.082 | Adenosine A3 receptor antagonist | 0.07 0.059 DB01828 0.082 0.04 DB00166 | DB00166 | |
| 0.032 | 0.099 | 0.061 | Histamine H4 receptor antagonist | 0.061 0.018 DB01828 | DB01828 | |
| 0.061 | 0.129 | 0.093 | Gastric antisecretory | 0.093 0.075 DB01828 | DB01828 | |
| 0.009 | 0.076 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.013 DB01828 | DB01828 | |
| 0.014 | 0.082 | 0.052 | Potassium channel small-conductance Ca-activated activator | 0.052 0.01 DB01828 | DB01828 | |
| 0.036 | 0.105 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.03 DB01828 | DB01828 | |
| 0.025 | 0.095 | 0.038 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.013 DB00166 | DB00166 | |
| 0.021 | 0.091 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.033 0.032 DB01828 | DB01828 | |
| 0.033 | 0.104 | 0.095 | Acetylcholine M5 receptor agonist | 0.095 0.023 DB01828 | DB01828 | |
| 0.034 | 0.107 | 0.075 | Alpha 2 adrenoreceptor agonist | 0.075 0.028 DB01828 | DB01828 | |
| 0.106 | 0.179 | 0.14 | Tumour necrosis factor antagonist | 0.14 0.114 DB01828 | DB01828 | |
| 0.007 | 0.081 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DB01828 | DB01828 | |
| 0.027 | 0.103 | 0.048 | Toll-Like receptor 8 antagonist | 0.048 0.044 DB01828 | DB01828 | |
| 0.018 | 0.094 | 0.115 | Histone deacetylase 7 inhibitor | 0.115 0.007 DBMET03082 | DBMET03082 | |
| 0.157 | 0.235 | 0.197 | Calpain 2 inhibitor | 0.197 0.19 DB01828 | DB01828 | |
| 0.026 | 0.104 | 0.069 | 5 Hydroxytryptamine 2 agonist | 0.069 0.02 DB01828 | DB01828 | |
| 0.006 | 0.084 | 0.03 | Vasopressin 2 agonist | 0.03 0.005 DB00166 | DB00166 | |
| 0.049 | 0.127 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 DB01828 | DB01828 | |
| 0.098 | 0.177 | 0.172 | LIM domain kinase 1 inhibitor | 0.172 0.079 DB01828 | DB01828 | |
| 0.03 | 0.112 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.033 DB01828 | DB01828 | |
| 0.051 | 0.134 | 0.079 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.079 0.072 DB01828 | DB01828 | |
| 0.031 | 0.115 | 0.051 | Potassium channel (Inward rectifier) activator | 0.051 0.034 DB01828 | DB01828 | |
| 0.02 | 0.109 | 0.044 | Delayed rectifier potassium channel blocker | 0.044 0.016 DB01828 | DB01828 | |
| 0.037 | 0.126 | 0.066 | Benzodiazepine agonist | 0.066 0.057 DB01828 | DB01828 | |
| 0.067 | 0.156 | 0.12 | MAP kinase kinase inhibitor | 0.12 0.074 DB01828 | DB01828 | |
| 0.023 | 0.112 | 0.084 | Histone deacetylase 9 inhibitor | 0.084 0.008 DBMET03082 | DBMET03082 | |
| 0.039 | 0.13 | 0.067 | 5 Hydroxytryptamine 5A antagonist | 0.067 0.034 DB01828 | DB01828 | |
| 0.013 | 0.104 | 0.03 | CDK4/cyclin D3 inhibitor | 0.03 0.018 DB01828 | DB01828 | |
| 0.023 | 0.114 | 0.035 | Potassium channel Kv1.1 blocker | 0.035 0.034 DB01828 | DB01828 | |
| 0.032 | 0.123 | 0.06 | CDC7 inhibitor | 0.06 0.057 DB01828 | DB01828 | |
| 0.009 | 0.101 | 0.033 | Leukotriene D4 antagonist | 0.033 0.014 DB00166 | DB00166 | |
| 0.021 | 0.117 | 0.043 | Protein kinase (CK1) epsilon inhibitor | 0.043 0.02 DB01828 | DB01828 | |
| 0.063 | 0.16 | 0.113 | Nav1.3 sodium channel blocker | 0.113 0.082 DB01828 | DB01828 | |
| 0.071 | 0.172 | 0.673 | Lipid peroxidase inhibitor | 0.521 0.005 DBMET03082 0.673 0.003 DB00166 | DB00166 | |
| 0.084 | 0.185 | 0.784 | Amyloid beta aggregation inhibitor | 0.784 0.004 DB00166 | DB00166 | |
| 0.102 | 0.207 | 0.159 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.159 0.131 DB01828 | DB01828 | |
| 0.089 | 0.194 | 0.179 | Aryl hydrocarbon receptor agonist | 0.179 0.114 DB01828 | DB01828 | |
| 0.064 | 0.169 | 0.145 | Toll-Like receptor 3 antagonist | 0.145 0.016 DB01828 | DB01828 | |
| 0.027 | 0.134 | 0.054 | Lysine-specific demethylase 1A inhibitor | 0.054 0.037 DB01828 | DB01828 | |
| 0.034 | 0.141 | 0.06 | 5 Hydroxytryptamine 5 antagonist | 0.06 0.036 DB01828 | DB01828 | |
| 0.032 | 0.148 | 0.067 | Acetylcholine M4 receptor antagonist | 0.067 0.062 DB01828 | DB01828 | |
| 0.037 | 0.153 | 0.07 | Potassium channel (ATP-sensitive) blocker | 0.07 0.041 DB01828 | DB01828 | |
| 0.051 | 0.169 | 0.196 | Topoisomerase II inhibitor | 0.112 0.074 DBMET03082 0.196 0.034 DB00166 | DB00166 | |
| 0.047 | 0.164 | 0.085 | Pim-3 kinase inhibitor | 0.085 0.067 DB01828 | DB01828 | |
| 0.025 | 0.146 | 0.057 | TRPA1 antagonist | 0.057 0.047 DB00166 | DB00166 | |
| 0.019 | 0.141 | 0.03 | ATR kinase inhibitor | 0.03 0.029 DB01828 | DB01828 | |
| 0.055 | 0.177 | 0.1 | Bromodomain-containing protein 2 inhibitor | 0.1 0.04 DB01828 | DB01828 | |
| 0.007 | 0.13 | 0.034 | Acetylcholine M4 receptor agonist | 0.034 0.018 DB01828 | DB01828 | |
| 0.035 | 0.165 | 0.06 | Phosphodiesterase 1A inhibitor | 0.06 0.042 DB01828 | DB01828 | |
| 0.012 | 0.143 | 0.051 | Histone deacetylase 8 inhibitor | 0.051 0.021 DBMET03082 | DBMET03082 | |
| 0.099 | 0.232 | 0.182 | Focal adhesion kinase 2 inhibitor | 0.182 0.086 DB01828 | DB01828 | |
| 0.027 | 0.16 | 0.048 | 5 Hydroxytryptamine 1B agonist | 0.048 0.047 DB01828 | DB01828 | |
| 0.039 | 0.175 | 0.058 | Phosphodiesterase 1C inhibitor | 0.058 0.056 DB01828 | DB01828 | |
| 0.023 | 0.167 | 0.141 | Farnesyltransferase inhibitor | 0.141 0.005 DBMET03082 | DBMET03082 | |
| 0.114 | 0.259 | 0.35 | Thyroid hormone antagonist | 0.35 0.073 DB00166 | DB00166 | |
| 0.007 | 0.153 | 0.018 | Adenosine A3 receptor agonist | 0.018 0.01 DB00166 | DB00166 | |
| 0.096 | 0.243 | 0.24 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.24 0.066 DB01828 | DB01828 | |
| 0.032 | 0.191 | 0.062 | Aryl hydrocarbon receptor antagonist | 0.062 0.049 DB01828 | DB01828 | |
| 0.026 | 0.186 | 0.131 | Histone deacetylase inhibitor | 0.131 0.01 DBMET03082 | DBMET03082 | |
| 0.059 | 0.229 | 0.105 | Nav1.5 sodium channel blocker | 0.105 0.076 DB01828 | DB01828 | |
| 0.009 | 0.181 | 0.042 | Histone deacetylase class I inhibitor | 0.042 0.025 DBMET03082 | DBMET03082 | |
| 0.017 | 0.201 | 0.052 | 5 Hydroxytryptamine 6 antagonist | 0.052 0.046 DB01828 | DB01828 | |
| 0.101 | 0.29 | 0.292 | Thyroid hormone beta antagonist | 0.292 0.092 DB00166 | DB00166 | |
| 0.009 | 0.203 | 0.184 | Nicotinic acid receptor 2 agonist | 0.184 0.004 DB00166 | DB00166 | |
| 0.033 | 0.228 | 0.141 | 5-Lipoxygenase inhibitor | 0.089 0.072 DBMET03082 0.141 0.041 DB00166 | DB00166 | |
| 0.053 | 0.251 | 0.121 | Activin receptor-like kinase 2 inhibitor | 0.121 0.095 DB01828 | DB01828 | |
| 0.024 | 0.223 | 0.059 | MAP kinase kinase 9 inhibitor | 0.059 0.034 DB00166 | DB00166 | |
| 0.024 | 0.225 | 0.06 | Nav1.7 sodium channel blocker | 0.06 0.058 DB01828 | DB01828 | |
| 0.041 | 0.242 | 0.091 | Alpha 2b adrenoreceptor antagonist | 0.091 0.084 DB01828 | DB01828 | |
| 0.037 | 0.238 | 0.12 | ErbB-3 antagonist | 0.12 0.029 DB00166 | DB00166 | |
| 0.005 | 0.216 | 0.679 | Calpain 1 inhibitor | 0.679 0.001 DB00166 | DB00166 | |
| 0.08 | 0.298 | 0.159 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.159 0.057 DB01828 | DB01828 | |
| 0.024 | 0.244 | 0.093 | Cathepsin B inhibitor | 0.093 0.019 DB00166 | DB00166 | |
| 0.042 | 0.269 | 0.12 | Toll-Like receptor 9 antagonist | 0.12 0.086 DB01828 | DB01828 | |
| 0.006 | 0.237 | 0.054 | Geranylgeranyltransferase I inhibitor | 0.054 0.005 DBMET03082 | DBMET03082 | |
| 0.023 | 0.256 | 0.096 | Bombesin 1 receptor agonist | 0.096 0.019 DBMET03082 | DBMET03082 | |
| 0.056 | 0.296 | 0.155 | Dual specificity phosphatase inhibitor | 0.155 0.089 DBMET03082 | DBMET03082 | |
| 0.005 | 0.259 | 0.103 | Antidiuretic hormone antagonist | 0.103 0.012 DB00166 | DB00166 | |
| 0.037 | 0.298 | 0.108 | Sodium channel (voltage-gated) blocker | 0.108 0.099 DB01828 | DB01828 | |
| 0.042 | 0.307 | 0.121 | Cyclooxygenase inhibitor | 0.121 0.098 DB00166 | DB00166 | |
| 0.041 | 0.351 | 0.194 | Dual specificity phosphatase 3 inhibitor | 0.194 0.064 DBMET03082 | DBMET03082 | |
| 0.011 | 0.34 | 0.024 | Complement factor 1r inhibitor | 0.024 0.023 DB01828 | DB01828 | |
| 0.048 | 0.422 | 0.337 | Tumour necrosis factor alpha release inhibitor | 0.337 0.041 DBMET03082 | DBMET03082 | |
| 0.094 | 0.471 | 0.189 | MAP kinase kinase 5 inhibitor | 0.189 0.047 DB01828 | DB01828 | |
| 0.125 | 0.511 | 0.2 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.2 0.166 DB01828 | DB01828 | |
| 0.068 | 0.461 | 0.793 | Growth factor agonist | 0.793 0.003 DB00166 | DB00166 | |
| 0.005 | 0.478 | 0.114 | Oxytocin antagonist | 0.114 0.009 DB00166 | DB00166 | |
| 0.004 | 0.517 | 0.18 | Histone deacetylase 10 inhibitor | 0.18 0.004 DBMET03082 | DBMET03082 | |
| 0.004 | 0.538 | 0.297 | Histone deacetylase 3 inhibitor | 0.297 0.004 DBMET03082 | DBMET03082 | |
| 0.003 | 0.557 | 0.086 | Vasopressin 1B antagonist | 0.086 0.005 DB00166 | DB00166 | |
| 0.005 | 0.567 | 0.324 | Histone deacetylase 11 inhibitor | 0.324 0.004 DBMET03082 | DBMET03082 | |
| 0.005 | 0.567 | 0.324 | Histone deacetylase class IV inhibitor | 0.324 0.004 DBMET03082 | DBMET03082 | |
| 0.003 | 0.574 | 0.064 | Vasopressin 1A antagonist | 0.064 0.01 DB00166 | DB00166 | |
| 0.011 | 0.613 | 0.041 | Thiazolidinedione | 0.041 0.008 DB00166 | DB00166 | |
| 0.003 | 0.637 | 0.074 | Vasopressin 1 antagonist | 0.074 0.012 DB00166 | DB00166 | |
| 0.004 | 0.648 | 0.246 | Histone deacetylase 2 inhibitor | 0.246 0.006 DBMET03082 | DBMET03082 | |
| 0.058 | 0.743 | 0.312 | MAP kinase kinase 6 inhibitor | 0.312 0.125 DB01828 | DB01828 | |
| 0.004 | 0.726 | 0.114 | Histone deacetylase 4 inhibitor | 0.114 0.005 DBMET03082 0.035 0.02 DB00166 | DBMET03082 | |
| 0.004 | 0.737 | 0.208 | Histone deacetylase 1 inhibitor | 0.208 0.006 DBMET03082 | DBMET03082 | |
| 0.004 | 0.739 | 0.153 | Histone deacetylase 5 inhibitor | 0.153 0.006 DBMET03082 | DBMET03082 | |
| 0.004 | 0.789 | 0.14 | Histone deacetylase class IIa inhibitor | 0.14 0.006 DBMET03082 | DBMET03082 | |
| 0.016 | 0.828 | 0.296 | MAP kinase kinase 8 inhibitor | 0.296 0.004 DB00166 | DB00166 | |
| 0.005 | 0.867 | 0.382 | Acetylcholinesterase inhibitor | 0.382 0.008 DB00166 | DB00166 | |
| 0.003 | 0.883 | 0.179 | Histone deacetylase class IIb inhibitor | 0.179 0.005 DBMET03082 | DBMET03082 | |
| 0.003 | 0.885 | 0.178 | Histone deacetylase 6 inhibitor | 0.178 0.005 DBMET03082 | DBMET03082 | |
| 0.005 | 0.893 | 0.13 | DNA directed RNA polymerase inhibitor | 0.13 0.032 DBMET03082 | DBMET03082 | |
| 0.003 | 0.892 | 0.14 | Histone deacetylase class II inhibitor | 0.14 0.006 DBMET03082 | DBMET03082 | |
| 0.004 | 0.9 | 0.621 | Butyrylcholinesterase inhibitor | 0.621 0.004 DB00166 | DB00166 | |
| 0.004 | 0.919 | 0.112 | MAP kinase kinase 10 inhibitor | 0.112 0.016 DB00166 | DB00166 | |
| 0.004 | 0.956 | 0.313 | Cholinergic | 0.313 0.017 DB00166 | DB00166 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |